Related Experiment Video
Updated: Apr 25, 2026
04:46
Isolation of Lymphocytes from Mouse Genital Tract Mucosa
Published on: September 3, 2012
14.1K
Summary
The fluorescent treponemal antibody-absorption test (FTA-ABS) did not show a high false positive rate in individuals with recurrent genital herpes, contrary to previous findings. Borderline results were common in both herpes patients and controls, warranting further investigation.
Area of Science:
- Infectious Diseases
- Immunology
- Sexually Transmitted Infections
Background:
- Recurrent genital herpes is a common condition.
- The fluorescent treponemal antibody-absorption test (FTA-ABS) is used for syphilis diagnosis.
- Previous studies suggested a potential for false positive FTA-ABS results in herpes patients.
Purpose of the Study:
- To evaluate the accuracy of the fluorescent treponemal antibody-absorption test (FTA-ABS) in individuals with recurrent genital herpes.
- To determine if recurrent genital herpes leads to false positive FTA-ABS results.
Main Methods:
- A cohort of 55 healthy individuals with documented recurrent genital herpes was tested.
- The fluorescent treponemal antibody-absorption test (FTA-ABS) was performed on all participants.
- Results were compared to a control group.
Main Results:
- The study did not confirm previous reports of a significant false positive rate for FTA-ABS in patients with genital herpes.
- A high incidence of borderline FTA-ABS test results was observed in both the herpes group and the control group.
- No statistically significant difference in false positive rates was found between the groups.
Conclusions:
- The fluorescent treponemal antibody-absorption test (FTA-ABS) appears reliable for syphilis screening in patients with recurrent genital herpes.
- The clinical significance of borderline FTA-ABS results in this population requires further study.
- The findings challenge previous assertions regarding FTA-ABS specificity in the context of genital herpes.
